Treatment of speech and voice disorders with botulinum toxin.
Ludlow
C L
CL
Speech and Voice Unit, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Md. 20892.
D000328:Adult; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000627:therapeutic use*; D004576:Electromyography; D005260:Female; D006801:Humans; D007267:Injections; D007821:Laryngeal Muscles / Q000503:physiopathology; D010699:Phonation; D013064:Speech Disorders / Q000628:therapy*; D013342:Stuttering / Q000503:physiopathology; D014832:Voice Disorders / Q000628:therapy*
D001905:Botulinum Toxins